Around 5% of adults worldwide suffer from depression, which is a prevalent mood disorder. Although effective treatments are available, some patients experience unpleasant side effects, and approximately 30.9% of patients either have a poor response or no response to medication. To improve the treatment options for depression, researchers are exploring complementary and alternative therapies.
A recent study published in the Nutrients journal investigated the potential of matcha tea powder as an antidepressant and the underlying mechanisms involved. The results indicated that matcha tea has antidepressant-like effects in a mouse model of depression.
Matcha, a traditional Japanese tea, has gained popularity for its health benefits, which include improving mood and mental performance in both humans and mice. However, more research is needed to understand its mechanisms of action.
To address this gap, Japanese researchers conducted a study to evaluate the anti-depressive effects of Matcha tea powder in mice. The results showed that the powder activates dopaminergic neural circuits and improves depression in certain mice, depending on their prior mental state. This research could pave the way for developing more effective antidepressants.
Depression is currently the most common mental disorder worldwide, and its prevalence continues to rise. Although the onset of depression varies among individuals, a reduction in dopamine in the brain is believed to contribute to the disease. Dopamine, a neurotransmitter and hormone, plays a crucial role in regulating mood and promoting feelings of happiness, accomplishment, and motivation.
Although various antidepressants have been developed to counter the effects of low dopamine, they often come with multiple side effects. Additionally, people may develop resistance to antidepressants, requiring higher doses or frequent changes in medication. This has prompted researchers to search for natural products with anti-depressant effects.
One such product is Matcha, which has gained popularity due to its potential health benefits. Made from the leaves of Camellia sinensis, which are rich in mood-boosting compounds, Matcha powder is traditionally used to make tea.
Consuming Matcha tea has been shown to improve anxiety-like behavior in mice by activating dopamine function via dopamine D1 receptor signaling. This dopamine boost may also improve the symptoms of depression. Dr. Yuki Kurauchi from Kumamoto University led a team of researchers to investigate the effects of Matcha tea powder in socially isolated mice, and their findings have been detailed in a paper published in the Nutrients journal.
For their experiments, the research team used stress-tolerant BALB/c and stress-susceptible C57BL/6J mice that were subjected to social isolation stress. The mice were orally administered a Matcha tea suspension, which appeared to reduce levels of depression in the stress-susceptible mice. This was demonstrated by their improved performance in tail suspension tests (TST), which are commonly used to evaluate depression in mice.
According to Dr. Kurauchi, Matcha tea was found to reduce “the immobility time only in stress-susceptible mice that experienced greater stress from social isolation” and showed “higher depression-like behavior, in comparison to the stress-tolerant mice.”
To understand the mechanism behind the anti-depressive effects of Matcha tea powder, the research team conducted an immunohistochemical analysis of the mice brains. The results showed that consumption of Matcha tea suspension activated the prefrontal cortex (PFC) and nucleus accumbens (NAc) in stress-susceptible mice. These brain regions play a crucial role in the dopaminergic circuit and are responsible for regulating dopamine levels in the brain.
Activation of these regions, indicated by an increase in the number of cells expressing c-Fos (an important indicator of neural activity), typically results in a boost in dopamine levels, leading to an elevated mood. Stress-susceptible mice with a shorter immobility time also had more c-Fos-positive cells in the ventral tegmental area (VTA) of their brains, which initiates dopaminergic activity, as well as in the PFC and NAc, indicating higher neural activity and dopamine production. In contrast, stress-tolerant mice did not show any such effects.
The team found further evidence to support their conclusion. When stress-susceptible mice were administered a dopamine D1 receptor blocker, the antidepressant-like effects of Matcha tea suspension were negated. Dr. Kurauchi connects the dots, stating that “These results suggest that Matcha tea powder exerts an antidepressant-like effect by activating the dopaminergic system of the brain, and this is influenced by the mental state of the individual.”
Dr. Kurauchi is positive about the potential implications of their study. In light of the sensitivity of stress-susceptible mice to the effect of Matcha tea suspension, but not stress-tolerant mice, he suggests that future evaluations of antidepressants in humans should take into account the differences in mental conditions among individuals.
“Also, incorporating Matcha into health promotion programs,” according to the author, “has potential to improve its widespread utility.”
Image Credit: Getty